Clinical trial Recruiting at 3 sites Interventional Ages 18 to 80

Using high-flow nasal cannulas to prevent oxygen drops during sedated GI endoscopy in critically ill patients

Official title: Effect of High Flow Nasal Cannula Oxygenation on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients: A Multicentre Randomised Controlled Trial

Run by Zhejiang University · NCT07252102 · Data updated 2026-11-12

This trial will test whether high-flow nasal cannulas during sedated gastrointestinal endoscopy can prevent low oxygen levels in critically ill (ASA 3–4) adults.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment450 (estimated)
SponsorZhejiang University
Academic / other
Locations3 sites (Shenzhen, Guangdong and 2 other locations)
StatusRecruiting
StartedNovember 20, 2025
Main results expectedDecember 28, 2026
Study endsDecember 30, 2026
Registry record updatedJanuary 20, 2026
Trial IDNCT07252102 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 having elective gastroenteroscopy with ASA grade 3–4, BMI 18–28 kg/m2, procedure time expected ≤60 minutes, and able to give informed consent are ideal candidates.

Probably not a fit

Patients who cannot use HFNC (nasal obstruction, recent nasal surgery/trauma, active nasal bleeding), those with COPD, acute respiratory infection or asthma attack, difficult airway, acute GI bleeding with shock, gastric outlet obstruction with retained contents, allergy to sedatives like propofol, or severe cognitive impairment are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Critically ill adults (ASA grade 3–4) scheduled for elective gastrointestinal endoscopy will be assigned to receive either high-flow nasal catheter oxygen or standard nasal catheter oxygen during sedation. The study compares the incidence of hypoxia, severe hypoxia, and subclinical respiratory depression using predefined SpO2 thresholds and durations. Investigators will also record respiratory- and sedation-related adverse events and procedure-related complications. The trial is conducted at multiple tertiary hospitals in China and focuses on procedures expected to last 60 minutes or less.

Why it matters

Potential benefit: If successful, HFNC could reduce episodes of low oxygen and related complications during sedated GI procedures in high-risk patients.

How similar studies have gone: Previous studies have shown HFNC reduces hypoxia during sedated endoscopy in ASA 1–2 and obese patients, but its benefit in ASA 3–4 critical patients remains to be confirmed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 18≤ age ≤80, gender is not limited;
2. Patients undergoing elective gastroenteroscopy or treatment;
3. ASA grade Ⅲ\~Ⅳ;
4. 18 kg/m2≤BMI≤28kg/m2;
5. The operation time of gastroenteroscopy is expected to be no more than 60min;
6. Clearly understand, voluntarily participate in the study, and have informed consent from myself or my family members.

Exclusion Criteria:

1. Patients with nasal congestion, nasal bleeding, recent nasal trauma, recent nasal surgery, increased intracranial pressure and skull fracture, etc., who can not perform high-flow nasal catheter oxygen;
2. acute respiratory infections and asthma attacks;
3. Patients diagnosed with COPD;
4. Clear difficult airway;
5. Acute upper gastrointestinal bleeding with shock;
6. Gastrointestinal obstruction with gastric content retention;
7. Allergic to sedatives such as propofol;
8. Persons with no capacity for civil conduct such as cognitive dysfunction.

Where it's running

  • Shenzhen Hospital of Southern Medical University
    Shenzhen, Guangdong, China
    Recruiting
  • Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
    Shenzhen, Guangdong, China
    Recruiting
  • The First Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.